The secretion of procoagulation and complement proteins has particular relevance in vascular diseases in which thrombosis and plaque vulnerability critically increase the risk of mortality (61, 62); therefore, targeting senescent cells in the atherosclerotic niche may reduce the probability of thrombosis or plaque rupture, as previously demonstrated (10). This evidence concerns the gene VTN and deep vein thrombosis.